Tarlatamab for previously treated advanced small-cell lung cancer: a single technology appraisal

Pickett, Karen, Hawa, Asyl, Cooper, Keith, Picot, Jo and Scott, David Alexander (2024) Tarlatamab for previously treated advanced small-cell lung cancer: a single technology appraisal Southampton Health Technology Assessments Centre 134pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to the National Institute of Health and Care Excellence (NICE) from Amgen on the clinical effectiveness and cost effectiveness of tarlatamab for treating previously treated advanced small-cell lung cancer (SCLC). It identifies the strengths and weakness of the CS.

Text

Tarlatamab EAG report - Version of Record

Available under License Creative Commons Attribution.

Download (1MB)

More information

Published date: 2024

Related URLs:

https://www.nice.org.uk/guidan...tee-papers

Identifiers

Local EPrints ID: 506586

URI: http://eprints.soton.ac.uk/id/eprint/506586

PURE UUID: 30f596f0-10fb-4b6b-ab37-d03fb1e8218f

ORCID for Karen Pickett:

orcid.org/0000-0002-8631-6465

ORCID for Keith Cooper:

orcid.org/0000-0002-0318-7670

ORCID for Jo Picot:

orcid.org/0000-0001-5987-996X

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

Catalogue record

Date deposited: 11 Nov 2025 17:57

Last modified: 12 Nov 2025 02:57

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Karen Pickett

Author: Asyl Hawa

Author: Keith Cooper

Author: Jo Picot

Author: David Alexander Scott

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information